2-(2-Chloroethoxy)benzoic acid | 953069-06-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-Chloroethoxy)benzoic acid
• CAS: 953069-06-2
• 化学式: C₉H₉ClO₃
• 分子量: 200.622
• InChiKey: KYTGNFGTZWJTLB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(2-Chloroethoxy)benzoic acid 、 (E)-5-(3-(2-(6,7-difluoroquinolin-2-yl)vinyl)benzyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 在 potassium carbonate 作用下， 以 4-甲基-2-戊酮 为溶剂， 反应 16.0h， 生成 2-(2-(5-(3-(2-(6,7-difluoroquinolin-2-yl)vinyl)benzyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)ethoxy)benzoic acid
  参考文献：
  名称：

  Synthesis and structure–activity relationships of γ-carboline derivatives as potent and selective cysLT1 antagonists

  摘要：

  A gamma-carboline series of cysLT(1) receptor antagonists has been prepared. Some of the compounds show good potencies both, in vitro and in vivo, compared to the standard compounds. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.094

文献信息

• Indolylpiperidine derivatives as antihistaminic aand antiallergic agents
  申请人：——

  公开号：US20040116471A1

  公开（公告）日：2004-06-17

  The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A 1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A 2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W 1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W 2 represents a 3-10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R 1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R 2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.

  本发明涉及公式（I）的吲哚基哌啶衍生物，其中：A1代表烷基，烷氧基，烷硫基，酰基烷基或羟基烷基；A2代表烷基，烷氧基，烷硫基，酰基烷基或烷氧基烷基；W1代表苯基，呋喃基或吡啶基，该基未取代或取代一个或多个卤素原子，烷氧基和/或烷基；W2代表3-10个成员的单环或双环基团，含有1-3个杂原子，该基团未取代或取代一个或多个卤素原子，烷基，烷氧基和/或羰基基团；R1代表氢或卤素原子或烷基，烷氧基或甲基氨基基团；R2代表羧基；以及其药学上可接受的盐；以及用于它们的制备过程，含有它们的制药组合物，以及它们作为抗组胺和抗过敏剂的医药用途。
• Indolylpiperidine derivatives as antihistaminic and antiallergic agents
  申请人：Almirall Prodesfarma S.A.

  公开号：US07189741B2

  公开（公告）日：2007-03-13

  The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W2 represents a 3–10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.

  本发明涉及式（I）的吲哚基哌啶衍生物，其中：A1代表烷基，烷氧基，烷硫基，酰基烷基或羟基烷基；A2代表烷基，烷氧基，烷硫基，酰基烷基或烷氧基烷基；W1代表苯基，呋喃基或吡啶基，其未取代或被一个或多个卤素原子，烷氧基和/或烷基取代；W2代表一个含1-3个杂原子的3-10环的单环或双环基团，其未取代或被一个或多个卤素原子，烷基，烷氧基和/或氧代基取代；R1代表氢或卤素原子或烷基，烷氧基或甲基氨基基团；R2代表羧基；以及其药学上可接受的盐；本发明还涉及制备它们的过程，含有它们的制药组合物以及它们作为抗组胺和抗过敏剂的医药用途。
• Method of monitoring a parameter of a hydrocarbon well, pipeline or formation
  申请人：JOHNSON MATTHEY PUBLIC LIMITED COMPANY

  公开号：US10365262B2

  公开（公告）日：2019-07-30

  A method of monitoring a parameter of a hydrocarbon well, pipeline or formation is provided. The method comprises introducing a tracer into the hydrocarbon well, pipeline or formation; producing a fluid from the hydrocarbon well, pipeline or formation; and analyzing the fluid to determine if the tracer is present in the fluid. The tracer comprises a halogenated alkoxylated-benzoic acid, an alkoxylated benzene sulfonic acid, a salt of a halogenated alkoxylated-benzoic acid or a salt of an alkoxylated benzene sulfonic acid.

  提供了一种监测碳氢化合物井、管道或地层参数的方法。该方法包括将示踪剂引入烃井、管道或地层；从烃井、管道或地层中产生流体；分析流体以确定流体中是否存在示踪剂。示踪剂包括卤代烷氧基化苯甲酸、烷氧基化苯磺酸、卤代烷氧基化苯甲酸的盐或烷氧基化苯磺酸的盐。
• Dock derived compound against laminin receptor (37 LR) and uses thereof
  申请人：Purdue Research Foundation

  公开号：US11022604B2

  公开（公告）日：2021-06-01

  An in silico screening method generated compounds that are against laminin receptor 37LR and their anti-cancer functions in prostate cancer cell lines are disclosed herein. A group of derivatives based on the hit compound from the in silico screening are synthesized and tested with improved IC50 value that can have relevant clinical use for prostate cancer or osteoarthritis.

  本文公开了一种针对层粘连蛋白受体 37LR 的化合物及其在前列腺癌细胞系中的抗癌功能的硅学筛选方法。根据硅学筛选中的命中化合物合成了一组衍生物，并对其进行了测试，其 IC50 值有所提高，可用于前列腺癌或骨关节炎的相关临床治疗。
• METHOD OF MONITORING A PARAMETER OF A HYDROCARBON WELL, PIPELINE OR FORMATION
  申请人：JOHNSON MATTHEY PUBLIC LIMITED COMPANY

  公开号：US20180284096A1

  公开（公告）日：2018-10-04

  A method of monitoring a parameter of a hydrocarbon well, pipeline or formation is provided. The method comprises introducing a tracer into the hydrocarbon well, pipeline or formation; producing a fluid from the hydrocarbon well, pipeline or formation; and analysing the fluid to determine if the tracer is present in the fluid. The tracer comprises a halogenated alkoxylated-benzoic acid, an alkoxylated benzene sulfonic acid, a salt of a halogenated alkoxylated-benzoic acid or a salt of an alkoxylated benzene sulfonic acid.